Oncology & Cancer

Breakthrough discovery to transform prostate cancer treatment

A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University ...

Neuroscience

Resynchronizing neurons to erase schizophrenia

Schizophrenia, an often severe and disabling psychiatric disorder, affects approximately 1 percent of the world's population. While research over the past few years has suggested that desynchronization of neurons may be the ...

Oncology & Cancer

Researchers identify key protein's role in cancer development

Researchers at the University of Cincinnati (UC) have identified a key protein as the first dual-function co-regulator of an estrogen receptor that plays a crucial role in cancer development, opening the way to improved therapeutic ...

Alzheimer's disease & dementia

New compound shows promise in treatment of Alzheimer's

Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer's and even restores memories in mice, they report Jan. 2 in the journal Cell Reports.

Attention deficit disorders

Caffeine could be a valid option for treating some ADHD symptoms

Attention Deficit Hyperactivity Disorder, or ADHD, is a psychiatric pathology for which diagnosis has increased exponentially over the last 20 years. In fact, current estimates suggest that this disorder affects between 2% ...

page 3 from 40